New tool aims to empower thyroid cancer patients in tough treatment choices
NCT ID NCT03892993
Summary
This study is creating and testing a decision-making guide for people with medullary thyroid cancer. The tool helps patients and their caregivers understand their options—like starting or stopping new drugs, joining clinical trials, or continuing regular monitoring—so they can have better conversations with their doctors. Researchers are enrolling 120 participants, including patients, caregivers, and healthcare providers, to see if the guide is helpful and easy to use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID GLAND MEDULLARY CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.